Author:
Kuhn W.,M�ller Th.,Winkel R.,Danielczik S.,Gerstner A.,H�cker R.,Mattern C.,Przuntek H.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference13 articles.
1. Birkmayer GJ, Birkmayer W (1989) Stimulation of endogenous L-dopa biosynthesis ? a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). Acta Neurol Scand [Suppl 126]: 183?187
2. Birkmayer JG, Vrecko C, Volc D, Birkmayer W (1993) Nicotinamide adenine dinucleotide (NADH) ? a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application. Acta Neurol Scand [Suppl 146]: 32?35
3. Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta B, Ott E (1989) The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients. J Neural Transm [PD Sect] 1: 297?302
4. Birkmayer W, Birkmayer JG, Vrecko K, Paletta B (1990) The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients. Adv Neurol 53: 545?549
5. Dizdar N, Kagedal B, Lindvall B (1994) Treatment of Parkinson's disease with NADH. Acta Neurol Scand 90: 345?347
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献